Search research articles
Contact Us
Filters
Showing results (221-230 of 264) with videos related to
Page
of 27
Sort By:
Cancer Discovery
|
November 23, 2017
FOXF1 Defines the Core-Regulatory Circuitry in Gastrointestinal Stromal Tumor
Leili Ran, Yuedan Chen, Jessica Sher, et al.
Cancer Research Communications
|
June 11, 2026
Predicting clinical sensitivities of PDGFRA exon 18 mutations to imatinib and avapritinib to optimize gastrointestinal stromal tumor treatment
Homma M Khosroyani, Alina Teuber, Ajia Town, et al.
Nature Genetics
|
September 22, 2014
PRC2 is recurrently inactivated through EED or SUZ12 loss in malignant peripheral nerve sheath tumors
William Lee, Sewit Teckie, Thomas Wiesner, et al.
Angewandte Chemie (International Ed. in English)
|
January 13, 2021
An Efficient Turing-Type Ag<sub>2</sub> Se-CoSe<sub>2</sub> Multi-Interfacial Oxygen-Evolving Electrocatalyst*
Xiao-Long Zhang, Peng-Peng Yang, Ya-Rong Zheng, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 24, 2016
Combined KIT and CTLA-4 Blockade in Patients with Refractory GIST and Other Advanced Sarcomas: A Phase Ib Study of Dasatinib plus Ipilimumab
Sandra P D'Angelo, Alexander N Shoushtari, Mary Louise Keohan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 3, 2022
A Phase Ib/II Randomized Study of RO4929097, a Gamma-Secretase or Notch Inhibitor with or without Vismodegib, a Hedgehog Inhibitor, in Advanced Sarcoma
Mrinal M Gounder, Evan Rosenbaum, Nian Wu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 30, 2021
Long-term Follow-up and Patterns of Response, Progression, and Hyperprogression in Patients after PD-1 Blockade in Advanced Sarcoma
Nicholas D Klemen, Sinchun Hwang, Martina Bradic, et al.
Journal for Immunotherapy of Cancer
|
April 2, 2022
Clinical, genomic, and transcriptomic correlates of response to immune checkpoint blockade-based therapy in a cohort of patients with angiosarcoma treated at a single center
Evan Rosenbaum, Cristina R Antonescu, Shaleigh Smith, et al.
Journal for Immunotherapy of Cancer
|
September 5, 2025
High transposable element expression in sarcomas is associated with increased immune infiltrates and improved outcomes including after immunotherapy
Benjamin A Nacev, Martina Bradic, Hyung Jun Woo, et al.
Cancer Cell
|
November 21, 2017
Aberrant Activation of a Gastrointestinal Transcriptional Circuit in Prostate Cancer Mediates Castration Resistance
Shipra Shukla, Joanna Cyrta, Devan A Murphy, et al.
Page
of 27
Search research articles
Search
Showing results (221-230 of 264) with videos related to
Sort By:
Page
of 27
Cancer Discovery
|
November 23, 2017
FOXF1 Defines the Core-Regulatory Circuitry in Gastrointestinal Stromal Tumor
Leili Ran, Yuedan Chen, Jessica Sher, et al.
Cancer Research Communications
|
June 11, 2026
Predicting clinical sensitivities of PDGFRA exon 18 mutations to imatinib and avapritinib to optimize gastrointestinal stromal tumor treatment
Homma M Khosroyani, Alina Teuber, Ajia Town, et al.
Nature Genetics
|
September 22, 2014
PRC2 is recurrently inactivated through EED or SUZ12 loss in malignant peripheral nerve sheath tumors
William Lee, Sewit Teckie, Thomas Wiesner, et al.
Angewandte Chemie (International Ed. in English)
|
January 13, 2021
An Efficient Turing-Type Ag<sub>2</sub> Se-CoSe<sub>2</sub> Multi-Interfacial Oxygen-Evolving Electrocatalyst*
Xiao-Long Zhang, Peng-Peng Yang, Ya-Rong Zheng, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 24, 2016
Combined KIT and CTLA-4 Blockade in Patients with Refractory GIST and Other Advanced Sarcomas: A Phase Ib Study of Dasatinib plus Ipilimumab
Sandra P D'Angelo, Alexander N Shoushtari, Mary Louise Keohan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 3, 2022
A Phase Ib/II Randomized Study of RO4929097, a Gamma-Secretase or Notch Inhibitor with or without Vismodegib, a Hedgehog Inhibitor, in Advanced Sarcoma
Mrinal M Gounder, Evan Rosenbaum, Nian Wu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 30, 2021
Long-term Follow-up and Patterns of Response, Progression, and Hyperprogression in Patients after PD-1 Blockade in Advanced Sarcoma
Nicholas D Klemen, Sinchun Hwang, Martina Bradic, et al.
Journal for Immunotherapy of Cancer
|
April 2, 2022
Clinical, genomic, and transcriptomic correlates of response to immune checkpoint blockade-based therapy in a cohort of patients with angiosarcoma treated at a single center
Evan Rosenbaum, Cristina R Antonescu, Shaleigh Smith, et al.
Journal for Immunotherapy of Cancer
|
September 5, 2025
High transposable element expression in sarcomas is associated with increased immune infiltrates and improved outcomes including after immunotherapy
Benjamin A Nacev, Martina Bradic, Hyung Jun Woo, et al.
Cancer Cell
|
November 21, 2017
Aberrant Activation of a Gastrointestinal Transcriptional Circuit in Prostate Cancer Mediates Castration Resistance
Shipra Shukla, Joanna Cyrta, Devan A Murphy, et al.
Page
of 27